CAT’s CEO, John Buchanan, and genome editing field lead Matt Josephson recently joined Ramon Amaral, CEO of Brazilian Fish, in a conversation with The Fish Site to share more of the story behind our new strategic partnership.
As previously announced, CAT is working with Brazilian Fish to integrate CAT’s genome editing technology into their breeding program — a major step in bringing this innovation out of the lab and into commercial-scale production.
Get the story on:
- What 45% yield gains could mean for producers, consumers, and the environment
- Why sterility is key for both environmental protection and production security
- How CAT is uniquely positioned — with a mobile lab, expert team, breeding program know-how, and in-house genotyping lab
- The opportunity genome editing presents to increase access to nutritious, high-quality protein
Read the full article here: https://thefishsite.com/articles/a-pivotal-moment-for-genome-editing-in-aquaculture